Millennium Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Millennium Management’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-80,938	Closed	-$21.9K	–	6873
2023 Q2	$21.9K	Sell	80,938 -24,608	-23%	-$14K	﹤0.01%	5615
2023 Q1	$59K	Buy	+105,546	New	+$77.7K	﹤0.01%	5572
2022 Q3	–	Sell	-92,286	Closed	-$293K	–	7683
2022 Q2	$293K	Buy	+92,286	New	+$332K	﹤0.01%	5400
2021 Q2	–	Sell	-31,033	Closed	-$425K	–	7317
2021 Q1	$425K	Buy	+31,033	New	+$630K	﹤0.01%	4954

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Millennium Management's SQZ Position: Q3 2023 in Review

Millennium Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 80,938 shares — an estimated $21.9K sold.

Millennium Management first reported a position in SQZ in Q1 2021 and held it in 4 quarters. The position peaked at $425K in Q1 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Millennium Management reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 80,938 SQZ Biotechnologies Company shares in Q3 2023, an estimated $21.9K.
Millennium Management first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 4 quarters.
Millennium Management's SQZ Biotechnologies Company position peaked at $425K in Q1 2021.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.